Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Aug 10, 2022
- Accession no.
- 0000899243-22-028246
- Filed
- Aug 10, 2022
- Trade date
- Aug 8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $381.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | MOption exerciseAcquired | +1,304 | $187.53 | +$244,539.12 | 37,381 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −222 | $290.32F2,F3 | −$64,451.04 | 37,159 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −424 | $291.53F2,F4 | −$123,608.72 | 36,735 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −210 | $293.02F2,F5 | −$61,534.2 | 36,525 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −302 | $293.99F2,F6 | −$88,784.98 | 36,223 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −146 | $295.14F2,F7 | −$43,090.44 | 36,077 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | MOption exerciseDisposed | −1,304 | $0.00 | $0 | 2,607 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53).
Referenced by the price of 1 transaction in Table I.